NANOVIRICIDES, INC. financial data

Symbol
NNVC on NYSE
Location
Shelton, CT
Fiscal year end
30 June
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 200% % -47%
Debt-to-equity 12% %
Return On Equity -96% % -13%
Return On Assets -84% % -9.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17,431,000 shares 19%
Common Stock, Shares, Outstanding 17,556,079 shares 25%
Entity Public Float $21,530,000 USD 90%
Common Stock, Value, Issued $176 USD 26%
Weighted Average Number of Shares Outstanding, Basic 17,082,425 shares 25%
Weighted Average Number of Shares Outstanding, Diluted 17,082,425 shares 25%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $4,609,076 USD -22%
General and Administrative Expense $3,611,420 USD -3.7%
Operating Income (Loss) $8,220,496 USD 15%
Nonoperating Income (Expense) $95,283 USD -52%
Net Income (Loss) Attributable to Parent $8,125,213 USD 14%
Earnings Per Share, Basic 0 USD/shares 34%
Earnings Per Share, Diluted 0 USD/shares 34%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,125,711 USD -71%
Assets, Current $1,252,566 USD -69%
Property, Plant and Equipment, Net $6,787,456 USD -7.8%
Intangible Assets, Net (Excluding Goodwill) $314,971 USD -2.6%
Assets $8,357,080 USD -29%
Employee-related Liabilities, Current $26,300 USD -44%
Accrued Liabilities, Current $26,300 USD -91%
Liabilities, Current $1,182,386 USD -28%
Liabilities $1,200,000 USD -27%
Retained Earnings (Accumulated Deficit) $150,626,919 USD -5.7%
Stockholders' Equity Attributable to Parent $7,174,694 USD -29%
Liabilities and Equity $8,357,080 USD -29%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,593,855 USD 39%
Net Cash Provided by (Used in) Financing Activities $1,245,319 USD -27%
Net Cash Provided by (Used in) Investing Activities $84,317 USD -80%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 17,556,079 shares 25%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,125,711 USD -71%
Deferred Tax Assets, Valuation Allowance $42,492,044 USD 6.8%
Deferred Tax Assets, Gross $42,492,044 USD 6.8%
Depreciation $672,742 USD -11%
Payments to Acquire Property, Plant, and Equipment $84,317 USD 80%
Property, Plant and Equipment, Gross $15,107,567 USD 0.63%
Deferred Tax Assets, Operating Loss Carryforwards $31,115,532 USD 6%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $157,801,428 USD 3.4%
Amortization of Intangible Assets $2,068 USD 0.05%
Deferred Tax Assets, Net of Valuation Allowance $0 USD